Clovis Oncology (CLVS) Prices 3.75M Offering at $20/Share

April 4, 2012 6:27 AM EDT Send to a Friend
Clovis Oncology, Inc. (Nasdaq: CLVS) announces the pricing of its underwritten public offering of 3,750,000 shares of its common stock at $20.00 per share, before underwriting discounts and commissions.

In addition, the underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock from Clovis Oncology to cover over-allotments, if any.

The offering is expected to close on April 10, 2012, subject to customary closing conditions.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings

Add Your Comment